Median overall survival
| Age, y . | All . | Selected . | Proportion . | OS ratio . | ||
|---|---|---|---|---|---|---|
| n . | OS . | n . | OS . | Selected/all % . | Selected/all . | |
| 16-55 | 554 | 1119 | 434 | 2546 | 78 | 2.3 |
| 56-65 | 437 | 359 | 275 | 562 | 63 | 1.6 |
| 66-75 | 738 | 184 | 341 | 385 | 46 | 2.1 |
| 76-89 | 968 | 80 | 178 | 189 | 18 | 2.4 |
| Total | 2697 | 196 | 1228 | 500 | 46 | 2.3 |
| Age, y . | All . | Selected . | Proportion . | OS ratio . | ||
|---|---|---|---|---|---|---|
| n . | OS . | n . | OS . | Selected/all % . | Selected/all . | |
| 16-55 | 554 | 1119 | 434 | 2546 | 78 | 2.3 |
| 56-65 | 437 | 359 | 275 | 562 | 63 | 1.6 |
| 66-75 | 738 | 184 | 341 | 385 | 46 | 2.1 |
| 76-89 | 968 | 80 | 178 | 189 | 18 | 2.4 |
| Total | 2697 | 196 | 1228 | 500 | 46 | 2.3 |
Median overall survival in days according to age for all patients versus those selected for de novo AML, fit for intensive treatment, and PS 0-II.